Evaluation of the URiSCAN 2 ACR Strip to estimate the urine albumin/creatinine ratios

Evaluation of the URiSCAN 2 ACR Strip to estimate the urine albumin/creatinine ratios INTRODUCTIONThe most common risk factors of chronic kidney disease are diabetes and hypertension. Preventing chronic kidney disease and early diagnosis of kidney damage are an important goal in primary health care. According to the Korea Health Insurance Review and Assessment Service, the number of Korean patients with chronic kidney disease increased by 37.1%, and total medical expenses increased by 47.6%, from 2006 to 2010. The average annual growth rate for the 5‐year period is of about 8.2% and 10.2%, respectively. According to the 2012 data, the total expenses for medical treatment of patients with end‐stage renal failure is similar to those of all cancer patients, and the expenses of medical treatment per patient are the highest among all diseases. Therefore, in patients with a high potential risk of kidney function, it is essential to periodically monitor the kidney function and to treat the progressive slowing down of the renal function as early as possible. An increased excretion of urinary protein, especially albumin, is an early finding of renal damage, and measurement of urinary albumin has been a useful marker for diagnosis and follow‐up of renal failure with estimated glomerular filtration rate. The urine albumin/creatinine ratio (ACR) test is also http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Clinical Laboratory Analysis Wiley

Evaluation of the URiSCAN 2 ACR Strip to estimate the urine albumin/creatinine ratios

Loading next page...
 
/lp/wiley/evaluation-of-the-uriscan-2-acr-strip-to-estimate-the-urine-albumin-JHwbh0mKuv
Publisher
Wiley Subscription Services, Inc., A Wiley Company
Copyright
Copyright © 2018 Wiley Periodicals, Inc.
ISSN
0887-8013
eISSN
1098-2825
D.O.I.
10.1002/jcla.22289
Publisher site
See Article on Publisher Site

Abstract

INTRODUCTIONThe most common risk factors of chronic kidney disease are diabetes and hypertension. Preventing chronic kidney disease and early diagnosis of kidney damage are an important goal in primary health care. According to the Korea Health Insurance Review and Assessment Service, the number of Korean patients with chronic kidney disease increased by 37.1%, and total medical expenses increased by 47.6%, from 2006 to 2010. The average annual growth rate for the 5‐year period is of about 8.2% and 10.2%, respectively. According to the 2012 data, the total expenses for medical treatment of patients with end‐stage renal failure is similar to those of all cancer patients, and the expenses of medical treatment per patient are the highest among all diseases. Therefore, in patients with a high potential risk of kidney function, it is essential to periodically monitor the kidney function and to treat the progressive slowing down of the renal function as early as possible. An increased excretion of urinary protein, especially albumin, is an early finding of renal damage, and measurement of urinary albumin has been a useful marker for diagnosis and follow‐up of renal failure with estimated glomerular filtration rate. The urine albumin/creatinine ratio (ACR) test is also

Journal

Journal of Clinical Laboratory AnalysisWiley

Published: Jan 1, 2018

Keywords: ; ; ; ;

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial